911 results on '"Bukowski, R."'
Search Results
2. Hazard I. Volume 1 : fire hazard assessment method
3. Hazard I. Volume 2 : representative example case documentation
4. Hazard I. Volume 3 : data base listing
5. Addressing the Needs of People using Elevators for Emergency Evacuation
6. Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study
7. Nitric oxide in the bovine oviduct: Influence on contractile activity and nitric oxide synthase isoforms localization
8. Fetal Growth in Early Pregnancy and Risk of Delivering Low Birth Weight Infant: Prospective Cohort Study
9. Cytokine Therapy of Metastatic Renal Cell Carcinoma: The Cleveland Clinic Experience
10. Maternal serum fructosamine levels and stillbirth: a case–control study of the Stillbirth Collaborative Research Network
11. Phase II trial of Fluorouracil, Leucovorin and Interferon-α
12. Hematologic effects of recombinant human Interleukin-6 (rhIL-6) in sarcoma patients receiving maid chemotherapy: phase I trial
13. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†
14. IL-2 Based Combination Therapy of Malignant Disease: Summary of the Phase I Experience at the Cleveland Clinic
15. Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency
16. Combination Therapy of Renal Cell Carcinoma with Interleukin-2 and Interferon Alpha: The Cleveland Clinic Experience
17. Tumor Infiltrating Lymphocytes in Human Renal Cell Carcinoma: Adoptive Immunotherapy and Characterization of Interleukin-2 Expanded Tumor-Infiltrating Lymphocytes
18. Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports
19. Identification of pathologically small fetuses using customized, ultrasound and population-based growth norms
20. Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
21. Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
22. Phase Ι trial of weekly Docetaxel and daily Temozolomide in patients with metastatic disease
23. Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
24. Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors
25. Downregulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest
26. Re-examination of the topographical localization of facial nucleus in the pig
27. Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes
28. Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
29. Photoacoustic signal dependence on sample-backing thermal resistance
30. Maternal serum fructosamine levels and stillbirth: a case–control study of the Stillbirth Collaborative Research Network.
31. Intrauterine growth restriction
32. Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas
33. Efficacy and safety of sorafenib in patients with advanced clear-cell renal-cell carcinoma (RCC) with bone metastases: results from the phase III TARGET study: V461
34. Flammability tests for railway passenger cars
35. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial
36. Phase I trial of weekly Docetaxel and daily Temozolomide in patients with metastatic disease
37. Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma
38. Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-αlb: A Second Member of the Interferon-α Family
39. Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
40. Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer
41. Amifostine: potential for clinically useful cytoprotection
42. A phase I trial of intrapleural recombinant human interferon α (rHuIFNα2b) in patients with malignant pleural effusions
43. Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer
44. A Phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma
45. Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects
46. A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer
47. USING COLOR-FLOW DOPPLER TO AID IN THE MEASUREMENT OF AMNIOTIC FLUID INDEX OVERESTIMATES OLIGOHYDRAMNIOS.
48. DELAY OF DELIVERY BY INHIBITION OF CYCLOOXYGENASE-2 IN THE RAT CERVIX.
49. THE EFFECTS OF CERVICAL APPLICATION OF iNOS, COX-1, AND COX-2 INHIBITORS ON DELIVERY IN RATS.
50. CLINICAL PHARMACOLOGY OF INTERLEUKIN-12 (rHuIL-12), IN PATIENTS WITH RENAL CELL CARCINOMA (RCC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.